(NLH) Nova Leap Health - Ratings and Ratios
Exchange: V • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA66980G1090
NLH: Care, Nursing, Companionship, Transportation, Meals, Housekeeping, Medication
Nova Leap Health Corp., together with its subsidiaries, provides home and home health care services in the United States and Canada. Its services include dementia care, companionship, personal and skilled nursing care, respite care, cooking and meal preparation, bathing, dressing, grooming, housekeeping, errands, transportation, and medication reminders. The company was incorporated in 2015 and is headquartered in Halifax, Canada., Web URL: https://novaleaphealth.com
Additional Sources for NLH Stock
NLH Stock Overview
| Market Cap in USD | 16m |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| GiC Sub-Industry | Health Care Facilities |
| IPO / Inception |
NLH Stock Ratings
| Growth 5y | -38.3% |
| Fundamental | 22.0% |
| Dividend | 0.0% |
| Rel. Strength Industry | 24 |
| Analysts | - |
| Fair Price Momentum | 0.21 CAD |
| Fair Price DCF | 0.12 CAD |
NLH Dividends
No Dividends PaidNLH Growth Ratios
| Growth Correlation 3m | 11.9% |
| Growth Correlation 12m | 3.4% |
| Growth Correlation 5y | -66.8% |
| CAGR 5y | -8.04% |
| CAGR/Max DD 5y | -0.09 |
| Sharpe Ratio 12m | 0.53 |
| Alpha | -1.89 |
| Beta | 1.02 |
| Volatility | 86.47% |
| Current Volume | 3k |
| Average Volume 20d | 12.5k |
What is the price of NLH stocks?
As of February 22, 2025, the stock is trading at CAD 0.26 with a total of 3,000 shares traded.
Over the past week, the price has changed by -3.70%, over one month by -5.45%, over three months by +4.00% and over the past year by +26.83%.
As of February 22, 2025, the stock is trading at CAD 0.26 with a total of 3,000 shares traded.
Over the past week, the price has changed by -3.70%, over one month by -5.45%, over three months by +4.00% and over the past year by +26.83%.
Is Nova Leap Health a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Nova Leap Health is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 22.03 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NLH as of February 2025 is 0.21. This means that NLH is currently overvalued and has a potential downside of -19.23%.
Neither. Based on ValueRay Fundamental Analyses, Nova Leap Health is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 22.03 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NLH as of February 2025 is 0.21. This means that NLH is currently overvalued and has a potential downside of -19.23%.
Is NLH a buy, sell or hold?
Nova Leap Health has no consensus analysts rating.
Nova Leap Health has no consensus analysts rating.
What are the forecast for NLH stock price target?
According to ValueRays Forecast Model, NLH Nova Leap Health will be worth about 0.3 in February 2026. The stock is currently trading at 0.26. This means that the stock has a potential downside of -3.85%.
According to ValueRays Forecast Model, NLH Nova Leap Health will be worth about 0.3 in February 2026. The stock is currently trading at 0.26. This means that the stock has a potential downside of -3.85%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 0.6 | 130.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 0.3 | -3.8% |